We empower the life sciences community to solve some of the world’s greatest challenges. We advocate for the industry and its diverse innovation pipeline. We propel solutions forward, so big dreams can make an even bigger impact. All of this adds up to people everywhere living longer, healthier, happier lives. And it’s all happening here.

Together, we are California Life Sciences.

Advocacy

Advocacy

Advancing life sciences through policy and advocacy leadership at all levels of government

Learn more
Membership

Membership

Members benefit from networking, cost savings, professional development and entrepreneurial support

Become a Member
Programs

Programs

Programs and partnerships that support diversity, entrepreneurship, education, and career development

See Our Impact

Sponsored content. Learn more.

CLS in the Community

Uncategorized

LABEST 2024

May 24, 2024
We had an amazing time at LABEST 2024! The event was a fantastic showcase of bioscience innovation, featuring groundbreaking presentations...
Read More
Advocacy Uncategorized

Amplifying Concerns with White House “March-In” Framework

May 24, 2024
As an advocate for strong life sciences intellectual property rights and a member of the Bayh Dole Coalition, CLS is...
Read More
Advocacy Uncategorized

CMS Drops “Stacking” Provision in MDRP Rule

May 24, 2024
In a major win for the life sciences industry, we were pleased to see CMS release a statement last week...
Read More
Uncategorized

Medscape Education – Realizing Potential through Rare Disease Education

May 9, 2024
For almost 30 years, Medscape Education has been providing clinician education in more than 30 specialties. In 2021, Medscape Education...
Read More
Uncategorized

Cache DNA – Encapsulating the Future of Rare Diseases

May 9, 2024
Storing the biomolecules of today in order to unlock the possibilities of tomorrow Traditionally, the journey to a rare disease...
Read More
Uncategorized

Hogan Lovells – Policy considerations for advancing rare disease therapies after the IRA

May 9, 2024
Author: Alice Valder Curran The U.S. Inflation Reduction Act of 2022 (IRA) includes major provisions adding complexity to market access,...
Read More
Uncategorized

Ultragenyx – The promise of new technologies to treat rare diseases will be realized only if we revolutionize our regulatory approach

May 9, 2024
Article Byline: Lisa M. Kahlman, executive director public policy & public affairs, Ultragenyx Developing therapies for rare and ultrarare diseases...
Read More
Uncategorized

2024 FAST Discovery Award Partners Announced

April 29, 2024
CLS announced this year’s Discovery Award partners, Chiesi Global Rare Disease, Servier and Wacker Biotech, committed to supporting aspiring life-science...
Read More
Advocacy Uncategorized

Council of State Biotech Associations Washington, D.C. Fly-In

April 29, 2024
On April 17, CLS participated in the CSBA’s annual fly-in on Capitol Hill. In meetings with the California delegation, CLS...
Read More
Advocacy Uncategorized

Alameda City Council Vote

April 29, 2024
On April 16th, the Alameda City Council took up a proposed ordinance to ban animal testing on City owned or...
Read More
Uncategorized

NEW MEMBER BENEFIT! Announcing CLS Insured

April 1, 2024
CLS has signed an exclusive agreement with HUB International, a leading insurance broker, to offer exclusive features and tailored benefits...
Read More
Uncategorized

CLS Member Benefit Highlight: CHUBB

April 1, 2024
Chubb and the National Center for the Middle Market (NCMM) released a new report with key indicators for middle market...
Read More

Upcoming Events

View All Events

Welcome to California Life Sciences Newest Members

Get Started with California Life Sciences

Become a member

Become a member

We’re stronger together. Explore membership with California Life Sciences today.

Learn more
Get the latest

Get the latest

Subscribe to our CLS Bulletin for member, advocacy, and industry updates.

Learn more